The ependymomas are classified on the basis of specific gene alterations, such as ZFTA or YAP1 fusions being characteristic in supratentorial ependymomas, and MYCN amplification being the norm in spinal ependymomas. This evidence concerns the gene YAP1 and ependymoma.